GMABGenmab A/S

$33.54

What is the market doing?

What the tape says about GMAB

Genmab A/S is +43% over the past year while the S&P 500 is +20%: 23 points ahead of the market.

+43%

1-year return · S&P 500 +20%

vs 200-day average
+14%

vs 200-day average · a clear uptrend

RSI (14)
55

RSI (14) · neutral

Below its 52-week high
5.1%

Below its 52-week high

2024-08-15$17.98 – $35.34 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$33.54
1 monthS&P 500 −0.30%
+12%
1 yearS&P 500 +20%
+43%
5 yearsS&P 500 +85%
−25%
vs 50-day average$29.71
+13%
52-week high
$35.34
52-week low
$23.82
Annualised volatility
35%
Calendar-year price return
YearReturn
2026 (year to date)+8.9%
2025+48%
2024−34%
2023−25%
2022+7.1%
2021−2.7%
2020+82%
2019+36%
2018−0.61%
2017−0.04%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan104 of 10−1.6%
Feb105 of 10+1.7%
Mar105 of 10−1.4%
Apr105 of 10+2.4%
May105 of 10+0.35%
Jun106 of 10+1.1%
Jul119 of 11+6.9%
Aug117 of 11+3.4%
Sep113 of 11−2.2%
Oct103 of 10−3.7%
Nov107 of 10+6.4%
Dec104 of 10−2.6%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.